Investment Notes: Coherence Neuro
Blackbird's investment note recapping its backing of Coherence Neuro and the neural implant startup's development milestones, institutional collaborations, and path toward first-in-human glioblastoma trials.
Company
Developing implantable neural interfaces to monitor and treat tumours via neural stimulation
Every investor coverage indicates participated in a round Coherence Neuro raised.
Investors whose own portfolio pages list Coherence Neuro, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Blackbird Ventures | its portfolio page ↗ |
Companies Coherence Neuro acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Coherence Neuro. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Blackbird's investment note recapping its backing of Coherence Neuro and the neural implant startup's development milestones, institutional collaborations, and path toward first-in-human glioblastoma trials.